Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/16/2011CN1612941B Methods of treating psychosis and schizophrenia based on polymorphisms in the CNTF gene
11/16/2011CN102246030A A method of characterizing phytochemicals from trigonella foenum graceum
11/16/2011CN102245773A Antibodies that specifically block the biological activity of a tumor antigen
11/16/2011CN102245758A Materials and methds to enhance hematopoietic stem cells engraftment procedures
11/16/2011CN102245636A Etoposide and doxorubicin conjugates for drug delivery
11/16/2011CN102245622A Novel aryl C-xyloside compounds, and cosmetic use
11/16/2011CN102245615A Methods of treating hepatic encephalopathy
11/16/2011CN102245614A Methylene amines of thieno [2, 3-d] pyrimidine and their use as adenosine A2a receptor antagonists
11/16/2011CN102245613A Phenyl and heteroaryl substituted thieno[2, 3-d] pyrimidines and their use as adenosine A2a receptor antagonists
11/16/2011CN102245611A mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/P13K/AKT pathway
11/16/2011CN102245610A Pyrrolotriazine kinase inhibitors
11/16/2011CN102245609A Imidazopyridazinecarbonitriles useful as kinase inhibitors
11/16/2011CN102245608A Azolotriazinone melanin concentrating hormone receptor-1 antagonists
11/16/2011CN102245607A Morpholinopurine derivative
11/16/2011CN102245605A Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
11/16/2011CN102245604A Anti-viral compounds
11/16/2011CN102245603A 2- (piperidin-1-yl) -4-azolyl-thiazole-5-carboxylic acid derivatives against bacterial infections
11/16/2011CN102245602A Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
11/16/2011CN102245601A Polymorph II of an antifungal compound
11/16/2011CN102245600A Pyrrolone melanin concentrating hormone receptor-1 antagonists
11/16/2011CN102245599A New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
11/16/2011CN102245597A Compounds useful for inhibiting CHK1
11/16/2011CN102245594A Process for the preparation of enantiomerically enriched proton pump inhibitors
11/16/2011CN102245593A Isoquinolinone derivatives
11/16/2011CN102245587A Trpv1 antagonists
11/16/2011CN102245586A Thiadiazole-substituted arylamides
11/16/2011CN102245584A Antagonists of lysophosphatidic acid receptors
11/16/2011CN102245583A Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases
11/16/2011CN102245581A Tetrahydrotriazine compounds for treating diseases associated with AMPK activity
11/16/2011CN102245576A Process for manufacturing substituted 3-pyridylmethyl ammonium bromides
11/16/2011CN102245574A Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
11/16/2011CN102245573A Heteroaryl derivatives as cftr modulators
11/16/2011CN102245571A 1-heterodiene derivative and harmful organism control agent
11/16/2011CN102245568A Cyclohexanecarboxamide derivatives useful as inhibitors of cholesteryl ester transfer protein
11/16/2011CN102245555A Isolate compounds from phaleria macrocarpa as anti cancer
11/16/2011CN102245214A Biodegradable polymer - bioactive moiety conjugates
11/16/2011CN102245211A Combined drug administration
11/16/2011CN102245209A Formulation for the buccal transmucosal administration of setrons
11/16/2011CN102245204A Alpha-galactosyl ceramide analogs and their use as immunotherapies, adjuvants, and intiviral, antibacterial, and anticancer agents
11/16/2011CN102245193A Feed for preventing and/or treating diseases due to clostridium sp. bacteria in livestock, and anti-clostridium agent
11/16/2011CN102245190A 抗微生物组合物 The antimicrobial composition
11/16/2011CN102245187A Modulation of TOLL-like receptor 3 expression by antisense oligonucleotides
11/16/2011CN102245186A Modulation of factor 11 expression
11/16/2011CN102245185A Combination of insulin with triazine derivatives and its use for treating diabetes
11/16/2011CN102245184A Enzastaurin for the treatment of cancer
11/16/2011CN102245183A New compounds v
11/16/2011CN102245182A Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates
11/16/2011CN102245181A Heterocyclic benzimidazoles as TRPM8 modulators
11/16/2011CN102245180A Compositions and methods for the treatment of altered alpha-synuclein function
11/16/2011CN102245179A Therapeutics for neurological disorders
11/16/2011CN102245178A Biosynthesis of derivatives of monacolin J
11/16/2011CN102245177A Oral composition
11/16/2011CN102245176A Fatty acids for use as a medicament
11/16/2011CN102245175A Antitumor combination combining AVE8062 and docetaxel
11/16/2011CN102245174A Synergistic effects between sphingosine-1-phosphate receptor antagonists and antimicrotubule agents
11/16/2011CN102245173A Ulipristal acetate tablets
11/16/2011CN102245169A Salicylic acid composition
11/16/2011CN102245167A Formulation for oral transmucosal administration of analgesic and/or antispasmodic molecules
11/16/2011CN102245166A Ophthalmic administration of a composition including brimonidine as a mist
11/16/2011CN102245033A Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals
11/16/2011CN102245032A Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals
11/16/2011CN102245027A Use of tetrakis (n-alkylpyridinium) -porphyrin derivatives for killing microbes or preventing growth
11/16/2011CN102245024A Inhibitors of diacylglycerol aclytransferase
11/16/2011CN102245023A Substituted dioxopiperidinyl phthalimide derivaties
11/16/2011CN102245022A Methods for treating gastrointestinal diseases
11/16/2011CN102241969A Small-molecule fluorescent probes for quinazoline alpha1-adrenergic receptors and application of small-molecule fluorescent probes
11/16/2011CN102241790A Amphipathic chitosan derivative and preparation method and application thereof
11/16/2011CN102241788A Preparation method for glucomannan acid hydrolyzed product
11/16/2011CN102241728A Steroid sapogenin derivatives and preparation method and application thereof
11/16/2011CN102241726A Glycyrrhetinic acid derivative and application thereof as antitumor medicament
11/16/2011CN102241720A L-nucleic acid derivative and processes for the synthesis thereof
11/16/2011CN102241710A Salidroside analogues as well as preparation method and application thereof
11/16/2011CN102241693A N,N'-di-(1-methyl-beta-carboline-3-formyl)-lysly aminoacid benzyl esters, synthetic method thereof and application thereof
11/16/2011CN102241690A Thienopyridine ester derivative containing nitrile group, its preparation method and its purpose
11/16/2011CN102241687A Drug of anti-ischemia/reperfusion injury
11/16/2011CN102241680A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
11/16/2011CN102241678A Antitumor effect and application of alicyclic structure-containing compound
11/16/2011CN102241675A (1R,3S)-1-(4-hydroxyl-3-methoxycarboxyl)-1,2,3,4-tetrahydro-beta-carboline-3-formyl amino acid derivatives as well as preparation method and application thereof
11/16/2011CN102241673A Acrylamide compounds and medicinal uses thereof
11/16/2011CN102241671A Precursor phase and use thereof for preparing the magnesium tetrahydrate salt of an omeprazole enantiomer
11/16/2011CN102241668A New S-omeprazole salts
11/16/2011CN102241667A 1-[(4-hydroxypiperidine-4-yl) methyl] pyridine-2(1H)-one derivatives, preparation method and use thereof
11/16/2011CN102241665A 4-(4,5-dimethoxycarboxyl-1,3-dithiolane-2-yl)benzoyl-L-amino acid benzyl ester as well as synthesis method and applications thereof
11/16/2011CN102241664A Aralkyl diamine derivatives and use thereof as antidepressants
11/16/2011CN102241657A Synthesis of isoflavone compound through Stille crossed coupling reaction
11/16/2011CN102241648A Multimedicine-resistance medicine-resistance taxane derivatives and preparation method and use thereof
11/16/2011CN102241646A Hexenone compound, and medical purpose thereof
11/16/2011CN102241644A Alpha-azyl-3-aryl propionamido thiazole derivative, preparation method and purpose thereof
11/16/2011CN102241636A Derivative of ligustrazine
11/16/2011CN102241628A (2E)-3-phenyl-N-[2,2,2-trichlorine-1-[[(8-quinolyl amino) thiomethyl]amino]ethyl]-2-acrylamide and medicinal uses thereof
11/16/2011CN102241627A Carbamide compound and its medicinal usage
11/16/2011CN102241625A 1-(substituted aryl)-5-((substituted arylamino) methyl) pyridine-2(1H) ketone compound, preparation method and use thereof
11/16/2011CN102241621A 5,5-disubstituted-2-iminopyrrolidine derivatives, preparation method thereof, and medical applications thereof
11/16/2011CN102241608A Retigabine compound and composition thereof
11/16/2011CN102241604A Amino acid modified curcumin, synthesis method thereof, and application thereof
11/16/2011CN102241596A O-aminoalcohol compounds, preparation method thereof and application thereof
11/16/2011CN102241593A Protoilludance norsesquiterpenoid esters and uses thereof
11/16/2011CN102240403A Method for preparing CaCO3 nanotube/podophyllum composite material
11/16/2011CN102240394A Use of interleukin-1receptor antagonist (IL-1Ra), and pharmaceutical compositions of IL-1Ra
11/16/2011CN102240374A Forgetfulness-preventing intelligence-promoting cerebral tonic pill for children
1 ... 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 ... 7860